Shopping Cart
clear

Request a Demo or a Quote

Your contact information:
Product Information:

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma